Junzo Sunamoto Selected Research

HER2p63 peptide

5/2002

Presentation of a major histocompatibility complex class 1-binding peptide by monocyte-derived dendritic cells incorporating hydrophobized polysaccharide-truncated HER2 protein complex: implications for a polyvalent immuno-cell therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Junzo Sunamoto Research Topics

Disease

2	Neoplasms (Cancer) 12/2006 - 05/2002

Drug/Important Bio-Agent (IBA)

1	PhytohemagglutininsIBA 12/2006
1	EnzymesIBA 12/2006
1	Messenger RNA (mRNA)IBA 12/2006
1	VaccinesIBA 12/2006
1	Peptides (Polypeptides)IBA 05/2002
1	Amino Acids FDA Link 05/2002
1	OligopeptidesIBA 05/2002
1	HER2p63 peptideIBA 05/2002
1	Proteins (Proteins, Gene)FDA Link 05/2002

Therapy/Procedure

1	Therapeutics 12/2006